medroxyprogesterone acetate has been researched along with Leukemia, Myeloid, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alhazmi, B; Beke, F; Bunce, CM; di Maio, A; Drayson, MT; Francis, T; Jiang, Y; Khanim, FL; Radotra, A; Southam, AD; Trova, S | 1 |
| Birtwistle, J; Bunce, CM; Davies, NJ; Drayson, MT; Green, RM; Gunther, UL; Hayden, RE; Khanim, FL; Lodi, A; Mountford, JC; Murray, JA; Ride, JP; Schrewe, H; Tiziani, S; Viant, MR | 1 |
| Bunce, CM; Craddock, CF; Drayson, MT; Hayden, RE; Holyoake, TL; Jackson, N; Khanim, FL; Lumley, M; Murray, JA | 1 |
1 trial(s) available for medroxyprogesterone acetate and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; Female; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Treatment Outcome | 2010 |
2 other study(ies) available for medroxyprogesterone acetate and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.
Topics: Anticonvulsants; Antioxidants; Bezafibrate; Cell Line, Tumor; Contraceptive Agents, Hormonal; Humans; Hypolipidemic Agents; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Medroxyprogesterone Acetate; NF-E2-Related Factor 2; Reactive Oxygen Species; Valproic Acid | 2022 |
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bezafibrate; Cell Differentiation; Cell Line, Tumor; Cholecalciferol; Drug Screening Assays, Antitumor; Glutathione; Humans; Hydroxyprostaglandin Dehydrogenases; I-kappa B Proteins; Leukemia, Myeloid, Acute; Medroxyprogesterone Acetate; PPAR gamma; Prostaglandin D2; Reactive Oxygen Species; Vitamin A | 2009 |